Please select the option that best describes you:
Topics:
Thrombocytopenia • Hematology • Benign Hematology • Gastroenterology • Cirrhosis • Hepatology
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
For example, someone needing a higher platelet count for dual antiplatelet agent use after coronary stent placement.
Answer from: at Academic Institution
In general, no, I would not use long term avatrombopag in patients with cirrhosis requiring higher platelet counts for medical therapy due to the perceived thrombotic risk and hemostatic abnormalities of patients with liver disease.One thing to note in assessing the risk of long-term TPO mimetic the...
Sign in or Register to read more